Monoamine Oxidase Inhibitor Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 115 pages | ID: M28A12A9C72CEN
Market Monitor Global

Abstracts

Monoamine Oxidase (MAO) Inhibitors are the drugs that are basically utilized for treatment of depression. These drugs usually work by prevention of breakdown of the serotonin, dopamine, and norepinephrine in CNS and maintains their availability. They also possess huge risk of distributing other neurotransmitters in the brain and digestive system causing side effects. The major side effects of MAO inhibitors are high blood pressure, insomnia and weight gain.

This report contains market size and forecasts of Monoamine Oxidase Inhibitor Drugs in Global, including the following market information:

Global Monoamine Oxidase Inhibitor Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Monoamine Oxidase Inhibitor Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Isocarboxazid Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Monoamine Oxidase Inhibitor Drugs include Takeda Pharmaceutical Company Limited, Mylan N.V., GlaxoSmithKline, Merck, Teva Pharmaceutical Industries, Bausch Health, Eli Lilly and Company, OrchidPharma and Validus Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Monoamine Oxidase Inhibitor Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Monoamine Oxidase Inhibitor Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Monoamine Oxidase Inhibitor Drugs Market Segment Percentages, by Type, 2021 (%)

• Isocarboxazid
• Phenelzine
• Tranylcypromine
• Others

Global Monoamine Oxidase Inhibitor Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Monoamine Oxidase Inhibitor Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Monoamine Oxidase Inhibitor Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Monoamine Oxidase Inhibitor Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Monoamine Oxidase Inhibitor Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Monoamine Oxidase Inhibitor Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Takeda Pharmaceutical Company Limited
• Mylan N.V.
• GlaxoSmithKline
• Merck
• Teva Pharmaceutical Industries
• Bausch Health
• Eli Lilly and Company
• OrchidPharma
• Validus Pharmaceuticals
• Indoco Remedies
• Teikoku Pharma
• H. Lundbeck
• Alliance Pharma
• Solvay
• Cipla
• Allergan
• Shionogi
• BioSyent
• Glenmark Pharmaceuticals Limited
• AstraZeneca
• Johnson & Johnson Private Limited
• Gedeon Richter
• Luye Pharma Group
• Bristol-Myers Squibb Company

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Monoamine Oxidase Inhibitor Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Monoamine Oxidase Inhibitor Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MONOAMINE OXIDASE INHIBITOR DRUGS OVERALL MARKET SIZE

2.1 Global Monoamine Oxidase Inhibitor Drugs Market Size: 2021 VS 2028
2.2 Global Monoamine Oxidase Inhibitor Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Monoamine Oxidase Inhibitor Drugs Players in Global Market
3.2 Top Global Monoamine Oxidase Inhibitor Drugs Companies Ranked by Revenue
3.3 Global Monoamine Oxidase Inhibitor Drugs Revenue by Companies
3.4 Top 3 and Top 5 Monoamine Oxidase Inhibitor Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Monoamine Oxidase Inhibitor Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monoamine Oxidase Inhibitor Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Monoamine Oxidase Inhibitor Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Monoamine Oxidase Inhibitor Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Monoamine Oxidase Inhibitor Drugs Market Size Markets, 2021 & 2028
  4.1.2 Isocarboxazid
  4.1.3 Phenelzine
  4.1.4 Tranylcypromine
  4.1.5 Others
4.2 By Type - Global Monoamine Oxidase Inhibitor Drugs Revenue & Forecasts
  4.2.1 By Type - Global Monoamine Oxidase Inhibitor Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Monoamine Oxidase Inhibitor Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Monoamine Oxidase Inhibitor Drugs Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Homecare
  5.1.4 Specialty Clinics
  5.1.5 Others
5.2 By Application - Global Monoamine Oxidase Inhibitor Drugs Revenue & Forecasts
  5.2.1 By Application - Global Monoamine Oxidase Inhibitor Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Monoamine Oxidase Inhibitor Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Monoamine Oxidase Inhibitor Drugs Market Size, 2021 & 2028
6.2 By Region - Global Monoamine Oxidase Inhibitor Drugs Revenue & Forecasts
  6.2.1 By Region - Global Monoamine Oxidase Inhibitor Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Monoamine Oxidase Inhibitor Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Monoamine Oxidase Inhibitor Drugs Revenue, 2017-2028
  6.3.2 US Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.3.3 Canada Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.3.4 Mexico Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Monoamine Oxidase Inhibitor Drugs Revenue, 2017-2028
  6.4.2 Germany Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.4.3 France Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.4.4 U.K. Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.4.5 Italy Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.4.6 Russia Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.4.8 Benelux Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Monoamine Oxidase Inhibitor Drugs Revenue, 2017-2028
  6.5.2 China Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.5.3 Japan Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.5.4 South Korea Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.5.6 India Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Monoamine Oxidase Inhibitor Drugs Revenue, 2017-2028
  6.6.2 Brazil Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.6.3 Argentina Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Monoamine Oxidase Inhibitor Drugs Revenue, 2017-2028
  6.7.2 Turkey Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.7.3 Israel Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028
  6.7.5 UAE Monoamine Oxidase Inhibitor Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Takeda Pharmaceutical Company Limited
  7.1.1 Takeda Pharmaceutical Company Limited Corporate Summary
  7.1.2 Takeda Pharmaceutical Company Limited Business Overview
  7.1.3 Takeda Pharmaceutical Company Limited Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.1.4 Takeda Pharmaceutical Company Limited Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.1.5 Takeda Pharmaceutical Company Limited Key News
7.2 Mylan N.V.
  7.2.1 Mylan N.V. Corporate Summary
  7.2.2 Mylan N.V. Business Overview
  7.2.3 Mylan N.V. Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.2.4 Mylan N.V. Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.2.5 Mylan N.V. Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.3.4 GlaxoSmithKline Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.4.4 Merck Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Teva Pharmaceutical Industries
  7.5.1 Teva Pharmaceutical Industries Corporate Summary
  7.5.2 Teva Pharmaceutical Industries Business Overview
  7.5.3 Teva Pharmaceutical Industries Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.5.4 Teva Pharmaceutical Industries Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.5.5 Teva Pharmaceutical Industries Key News
7.6 Bausch Health
  7.6.1 Bausch Health Corporate Summary
  7.6.2 Bausch Health Business Overview
  7.6.3 Bausch Health Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.6.4 Bausch Health Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.6.5 Bausch Health Key News
7.7 Eli Lilly and Company
  7.7.1 Eli Lilly and Company Corporate Summary
  7.7.2 Eli Lilly and Company Business Overview
  7.7.3 Eli Lilly and Company Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.7.4 Eli Lilly and Company Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.7.5 Eli Lilly and Company Key News
7.8 OrchidPharma
  7.8.1 OrchidPharma Corporate Summary
  7.8.2 OrchidPharma Business Overview
  7.8.3 OrchidPharma Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.8.4 OrchidPharma Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.8.5 OrchidPharma Key News
7.9 Validus Pharmaceuticals
  7.9.1 Validus Pharmaceuticals Corporate Summary
  7.9.2 Validus Pharmaceuticals Business Overview
  7.9.3 Validus Pharmaceuticals Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.9.4 Validus Pharmaceuticals Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.9.5 Validus Pharmaceuticals Key News
7.10 Indoco Remedies
  7.10.1 Indoco Remedies Corporate Summary
  7.10.2 Indoco Remedies Business Overview
  7.10.3 Indoco Remedies Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.10.4 Indoco Remedies Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.10.5 Indoco Remedies Key News
7.11 Teikoku Pharma
  7.11.1 Teikoku Pharma Corporate Summary
  7.11.2 Teikoku Pharma Business Overview
  7.11.3 Teikoku Pharma Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.11.4 Teikoku Pharma Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.11.5 Teikoku Pharma Key News
7.12 H. Lundbeck
  7.12.1 H. Lundbeck Corporate Summary
  7.12.2 H. Lundbeck Business Overview
  7.12.3 H. Lundbeck Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.12.4 H. Lundbeck Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.12.5 H. Lundbeck Key News
7.13 Alliance Pharma
  7.13.1 Alliance Pharma Corporate Summary
  7.13.2 Alliance Pharma Business Overview
  7.13.3 Alliance Pharma Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.13.4 Alliance Pharma Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.13.5 Alliance Pharma Key News
7.14 Solvay
  7.14.1 Solvay Corporate Summary
  7.14.2 Solvay Business Overview
  7.14.3 Solvay Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.14.4 Solvay Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.14.5 Solvay Key News
7.15 Cipla
  7.15.1 Cipla Corporate Summary
  7.15.2 Cipla Business Overview
  7.15.3 Cipla Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.15.4 Cipla Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.15.5 Cipla Key News
7.16 Allergan
  7.16.1 Allergan Corporate Summary
  7.16.2 Allergan Business Overview
  7.16.3 Allergan Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.16.4 Allergan Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.16.5 Allergan Key News
7.17 Shionogi
  7.17.1 Shionogi Corporate Summary
  7.17.2 Shionogi Business Overview
  7.17.3 Shionogi Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.17.4 Shionogi Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.17.5 Shionogi Key News
7.18 BioSyent
  7.18.1 BioSyent Corporate Summary
  7.18.2 BioSyent Business Overview
  7.18.3 BioSyent Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.18.4 BioSyent Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.18.5 BioSyent Key News
7.19 Glenmark Pharmaceuticals Limited
  7.19.1 Glenmark Pharmaceuticals Limited Corporate Summary
  7.19.2 Glenmark Pharmaceuticals Limited Business Overview
  7.19.3 Glenmark Pharmaceuticals Limited Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.19.4 Glenmark Pharmaceuticals Limited Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.19.5 Glenmark Pharmaceuticals Limited Key News
7.20 AstraZeneca
  7.20.1 AstraZeneca Corporate Summary
  7.20.2 AstraZeneca Business Overview
  7.20.3 AstraZeneca Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.20.4 AstraZeneca Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.20.5 AstraZeneca Key News
7.21 Johnson & Johnson Private Limited
  7.21.1 Johnson & Johnson Private Limited Corporate Summary
  7.21.2 Johnson & Johnson Private Limited Business Overview
  7.21.3 Johnson & Johnson Private Limited Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.21.4 Johnson & Johnson Private Limited Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.21.5 Johnson & Johnson Private Limited Key News
7.22 Gedeon Richter
  7.22.1 Gedeon Richter Corporate Summary
  7.22.2 Gedeon Richter Business Overview
  7.22.3 Gedeon Richter Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.22.4 Gedeon Richter Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.22.5 Gedeon Richter Key News
7.23 Luye Pharma Group
  7.23.1 Luye Pharma Group Corporate Summary
  7.23.2 Luye Pharma Group Business Overview
  7.23.3 Luye Pharma Group Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.23.4 Luye Pharma Group Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.23.5 Luye Pharma Group Key News
7.24 Bristol-Myers Squibb Company
  7.24.1 Bristol-Myers Squibb Company Corporate Summary
  7.24.2 Bristol-Myers Squibb Company Business Overview
  7.24.3 Bristol-Myers Squibb Company Monoamine Oxidase Inhibitor Drugs Major Product Offerings
  7.24.4 Bristol-Myers Squibb Company Monoamine Oxidase Inhibitor Drugs Revenue in Global Market (2017-2022)
  7.24.5 Bristol-Myers Squibb Company Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Monoamine Oxidase Inhibitor Drugs Market Opportunities & Trends in Global Market
Table 2. Monoamine Oxidase Inhibitor Drugs Market Drivers in Global Market
Table 3. Monoamine Oxidase Inhibitor Drugs Market Restraints in Global Market
Table 4. Key Players of Monoamine Oxidase Inhibitor Drugs in Global Market
Table 5. Top Monoamine Oxidase Inhibitor Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Monoamine Oxidase Inhibitor Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Monoamine Oxidase Inhibitor Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Monoamine Oxidase Inhibitor Drugs Product Type
Table 9. List of Global Tier 1 Monoamine Oxidase Inhibitor Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monoamine Oxidase Inhibitor Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Monoamine Oxidase Inhibitor Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Monoamine Oxidase Inhibitor Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Monoamine Oxidase Inhibitor Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Monoamine Oxidase Inhibitor Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Pharmaceutical Company Limited Corporate Summary
Table 31. Takeda Pharmaceutical Company Limited Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 32. Takeda Pharmaceutical Company Limited Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Mylan N.V. Corporate Summary
Table 34. Mylan N.V. Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 35. Mylan N.V. Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 38. GlaxoSmithKline Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 41. Merck Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Teva Pharmaceutical Industries Corporate Summary
Table 43. Teva Pharmaceutical Industries Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 44. Teva Pharmaceutical Industries Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Bausch Health Corporate Summary
Table 46. Bausch Health Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 47. Bausch Health Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly and Company Corporate Summary
Table 49. Eli Lilly and Company Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 50. Eli Lilly and Company Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 51. OrchidPharma Corporate Summary
Table 52. OrchidPharma Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 53. OrchidPharma Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Validus Pharmaceuticals Corporate Summary
Table 55. Validus Pharmaceuticals Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 56. Validus Pharmaceuticals Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Indoco Remedies Corporate Summary
Table 58. Indoco Remedies Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 59. Indoco Remedies Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Teikoku Pharma Corporate Summary
Table 61. Teikoku Pharma Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 62. Teikoku Pharma Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 63. H. Lundbeck Corporate Summary
Table 64. H. Lundbeck Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 65. H. Lundbeck Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Alliance Pharma Corporate Summary
Table 67. Alliance Pharma Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 68. Alliance Pharma Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Solvay Corporate Summary
Table 70. Solvay Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 71. Solvay Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 72. Cipla Corporate Summary
Table 73. Cipla Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 74. Cipla Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 75. Allergan Corporate Summary
Table 76. Allergan Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 77. Allergan Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 78. Shionogi Corporate Summary
Table 79. Shionogi Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 80. Shionogi Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 81. BioSyent Corporate Summary
Table 82. BioSyent Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 83. BioSyent Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 84. Glenmark Pharmaceuticals Limited Corporate Summary
Table 85. Glenmark Pharmaceuticals Limited Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 86. Glenmark Pharmaceuticals Limited Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 87. AstraZeneca Corporate Summary
Table 88. AstraZeneca Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 89. AstraZeneca Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 90. Johnson & Johnson Private Limited Corporate Summary
Table 91. Johnson & Johnson Private Limited Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 92. Johnson & Johnson Private Limited Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 93. Gedeon Richter Corporate Summary
Table 94. Gedeon Richter Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 95. Gedeon Richter Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 96. Luye Pharma Group Corporate Summary
Table 97. Luye Pharma Group Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 98. Luye Pharma Group Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 99. Bristol-Myers Squibb Company Corporate Summary
Table 100. Bristol-Myers Squibb Company Monoamine Oxidase Inhibitor Drugs Product Offerings
Table 101. Bristol-Myers Squibb Company Monoamine Oxidase Inhibitor Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Monoamine Oxidase Inhibitor Drugs Segment by Type in 2021
Figure 2. Monoamine Oxidase Inhibitor Drugs Segment by Application in 2021
Figure 3. Global Monoamine Oxidase Inhibitor Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Monoamine Oxidase Inhibitor Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Monoamine Oxidase Inhibitor Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Monoamine Oxidase Inhibitor Drugs Revenue in 2021
Figure 8. By Type - Global Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 12. US Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 24. China Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Monoamine Oxidase Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Monoamine Oxidase Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda Pharmaceutical Company Limited Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mylan N.V. Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Pharmaceutical Industries Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bausch Health Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly and Company Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. OrchidPharma Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Validus Pharmaceuticals Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Indoco Remedies Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Teikoku Pharma Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. H. Lundbeck Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Alliance Pharma Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Solvay Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Cipla Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Allergan Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Shionogi Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. BioSyent Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Glenmark Pharmaceuticals Limited Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. AstraZeneca Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Johnson & Johnson Private Limited Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Gedeon Richter Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Luye Pharma Group Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Bristol-Myers Squibb Company Monoamine Oxidase Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)